Clinical Trial Detail

NCT ID NCT02993523
Title A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Elderly Subjects With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

Therapies

Azacitidine + Venetoclax

Azacitidine

Age Groups: senior adult

No variant requirements are available.